🚨GI/Hep Fellowships start next week‼️ @HepCommJournal has the 📑 you need to thrive 💫 #GIHepFellowshipBootcamp First up, you get a consult for a #LiverMass, ✅ out this review about benign liver masses❕ 📍Hemangiomas 📍FNH 📍Hepatic Adenomas 📍Cysts https://t.co/4UEGFrMO8U

Do you also dream of preventing liver cancer? Must read: https://t.co/10KR8hSU8h

Fleet dashcams for commercial vehicles. Full integration with telematics for video exceptions, driver coaching and accident video. Live view. In &/or Out recording.

Neehar made me respect AFP, among the many things he has taught me (I recommend his recent editorial, fig 1) So I asked him, maybe should we have a review just on AFP? he said, yes, from @JuDongYang1 https://t.co/OMORnM6JnS It is a masterclass (fig 2)

🚨 Liver Biopsy remains a 🔑 tool in our 🧰 , so #GIHepFellowshipBootcamp is here to get you ready to understand: 💉Utility of biopsy across conditions❕ 💉Biopsy histologic characteristics❕ 💡The table below is GOLD 🏆 https://t.co/eUOMCGDjdN

MUST READ Endohepatology: Current perspectives and future directions. @AhmadBazarbashi and @allie_schulman in @HepCommJournal https://t.co/wJIq1kMxi4

Everyone starts somewhere. The person with $100,000 invested today once had their first $100. The difference? They started. Your turn. Let Mamo grow your @USDC, always earning the best rate and auto-compounding returns without needing to lift a finger.

📑 Unraveling enhanced liver regeneration in ALPPS: Integrating multi-omics profiling and in vivo CRISPR in mouse models https://t.co/gvBQAy8WeR

📑 Natural language processing to detect steatotic liver disease from the EHR is fast, scalable, and highly accurate‼️ AI is transforming liver disease detection ➡️ intervention❕ @bkyalwazi @jlouissaint89 #LiverTwitter #AI #NLP #SLD https://t.co/Vl9zy9hjhZ

It is on

Did you know?📈 All #AASLD journals are in Quartile 1 in Gastroenterology & #Hepatology for 2024: HEPATOLOGY: 16.8 Hepatology Comm: 4.6 Liver Transplantation: 4.2 Our journals’ influence continues to grow. Read the latest groundbreaking #research: https://t.co/SiBOD7pgar

💡 A milestone for Smart Money @BitcoinCom has partnered with Concordium to bring age-verified payments to 75+ million worldwide.

📑 Information overload, financial constraints, and psychological burdens are among the barriers faced by marginalized groups seeking curative treatments for #HCC‼️ https://t.co/qt9sdy2Zym

📑 Moderate alcohol-associated hepatitis: A real-world multicenter study‼️ mAH has ⬆️ 💀 rates, driven by age, organ failure, infections, and variceal 🩸 . Current risk scores perform poorly in mAH https://t.co/oi9ZNE20oY

📑 Treatment of #pruritus in primary sclerosing cholangitis: Analysis of the consortium for autoimmune liver disease registry❕ #OpenAccess https://t.co/HEtEibPmMe

1⃣ in 4⃣ transplant hepatologists in US screened ➕ for unhealthy alcohol use 🔖 @HepCommJournal 🔑Critical need for accessible physician wellness programs & reduced stigma 👤@CCoeMD @ArpanPatelMD 👥@NicoleRPrause @jasleensinghmd @KPourmandMD et al 👉 https://t.co/O3utPrpSVY

Futures Traders: Profits shouldn't be locked away for weeks. That's why we offer daily withdrawals from day one, no payout windows, and zero withdrawal limits in PRO.

⚡ Join the #HepMadness! Exceptional liver articles from our very own @LtxJournal and @HepCommJournal are going head-to-head — tournament style. Submit your bracket to compete by Friday, Oct. 31, at 5 p.m. ET, and see who will come out on top. @LiverFellow https://t.co/Xaeb2dJ9HH

Sarcopenia is common in cirrhosis So you should: 1. Recognize malnutrition 2. Address malnutrition 3. Promote exercise 4. Even supplement testosterone But don’t screen for it Not an independent mortality predictor https://t.co/brgRuJgtKu

📚 Our writer ✍️ Urmi Chaudhuri presents Autoimmune Hepatitis for #HepMadness2025 🩺✨ #HepMadness2025 |@LiverFellow |@AASLDtweets

Buckle up, Liver Lovers. It’s theme time! 🎉 🔅Over the next few days, we’ll spotlight all 16 #HepMadness2025 themes. 🔅Each one making its case for why it should advance to the next round. ⚡️ 16 powerhouse topics. Are you ready to explore, debate, and crown the champion?👑

Cannot express how much this has helped me throughout the start of Fellowship #Livertwitter @BIDMC_GI

📑 The current applications and future directions of #terlipressin‼️ https://t.co/CxaXLiq3Nu

📑 Evidence-based criteria for identifying at-risk individuals requiring #liver disease screening 🔍 https://t.co/DFSXgSkJ29

Many of our friends are in need - how can we help each other 1 in 4 hepatologists Report unhealthy alcohol use https://t.co/Qxri2LG0od